[DPHARMA] QoQ Quarter Result on 30-Sep-2016 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
21-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Sep-2016 [#3]
Profit Trend
QoQ- 40.82%
YoY- -26.46%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 117,049 120,994 74,033 80,302 79,135 79,470 89,401 19.69%
PBT 12,642 11,176 6,299 7,516 7,723 9,941 17,529 -19.59%
Tax -3,001 -2,558 2,532 -1,290 -3,782 -2,113 0 -
NP 9,641 8,618 8,831 6,226 3,941 7,828 17,529 -32.89%
-
NP to SH 9,653 8,618 8,428 6,341 4,503 7,843 15,335 -26.57%
-
Tax Rate 23.74% 22.89% -40.20% 17.16% 48.97% 21.26% 0.00% -
Total Cost 107,408 112,376 65,202 74,076 75,194 71,642 71,872 30.74%
-
Net Worth 463,071 463,071 454,703 451,913 446,334 457,492 270,177 43.26%
Dividend
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Div 6,973 - 11,158 - 6,973 - 9,172 -16.71%
Div Payout % 72.25% - 132.40% - 154.87% - 59.82% -
Equity
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Net Worth 463,071 463,071 454,703 451,913 446,334 457,492 270,177 43.26%
NOSH 278,959 278,959 278,959 278,959 278,959 278,959 278,959 0.00%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 8.24% 7.12% 11.93% 7.75% 4.98% 9.85% 19.61% -
ROE 2.08% 1.86% 1.85% 1.40% 1.01% 1.71% 5.68% -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 41.96 43.37 26.54 28.79 28.37 28.49 53.61 -15.08%
EPS 3.46 3.43 3.41 2.23 1.41 2.81 9.19 -47.89%
DPS 2.50 0.00 4.00 0.00 2.50 0.00 5.50 -40.91%
NAPS 1.66 1.66 1.63 1.62 1.60 1.64 1.62 1.64%
Adjusted Per Share Value based on latest NOSH - 278,959
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 12.17 12.58 7.70 8.35 8.23 8.26 9.29 19.74%
EPS 1.00 0.90 0.88 0.66 0.47 0.82 1.59 -26.61%
DPS 0.72 0.00 1.16 0.00 0.72 0.00 0.95 -16.88%
NAPS 0.4814 0.4814 0.4727 0.4698 0.464 0.4756 0.2809 43.25%
Price Multiplier on Financial Quarter End Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 -
Price 2.25 2.31 1.98 2.06 2.04 2.55 2.62 -
P/RPS 5.36 5.33 7.46 7.16 7.19 8.95 4.89 6.31%
P/EPS 65.02 74.77 65.54 90.63 126.38 90.70 28.49 73.42%
EY 1.54 1.34 1.53 1.10 0.79 1.10 3.51 -42.28%
DY 1.11 0.00 2.02 0.00 1.23 0.00 2.10 -34.65%
P/NAPS 1.36 1.39 1.21 1.27 1.28 1.55 1.62 -11.01%
Price Multiplier on Announcement Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 25/08/17 22/05/17 24/02/17 21/11/16 22/08/16 18/05/16 23/02/16 -
Price 2.03 2.32 2.23 2.10 2.14 2.40 2.61 -
P/RPS 4.84 5.35 8.40 7.30 7.54 8.42 4.87 -0.41%
P/EPS 58.66 75.10 73.81 92.39 132.57 85.36 28.39 62.29%
EY 1.70 1.33 1.35 1.08 0.75 1.17 3.52 -38.47%
DY 1.23 0.00 1.79 0.00 1.17 0.00 2.11 -30.24%
P/NAPS 1.22 1.40 1.37 1.30 1.34 1.46 1.61 -16.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment